AquaBounty Technologies, Inc. (NASDAQ:AQB) Short Interest Up 283.2% in February

AquaBounty Technologies, Inc. (NASDAQ:AQB) was the recipient of a large increase in short interest in the month of February. As of February 27th, there was short interest totaling 34,899 shares, an increase of 283.2% from the February 12th total of 9,108 shares. Based on an average daily volume of 26,794 shares, the short-interest ratio is presently 1.3 days. Approximately 0.9% of the shares of the stock are short sold. Approximately 0.9% of the shares of the stock are short sold. Based on an average daily volume of 26,794 shares, the short-interest ratio is presently 1.3 days.

Institutional Inflows and Outflows

An institutional investor recently raised its position in AquaBounty Technologies stock. Renaissance Technologies LLC grew its holdings in shares of AquaBounty Technologies, Inc. (NASDAQ:AQB) by 311.9% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 121,585 shares of the company’s stock after acquiring an additional 92,065 shares during the quarter. Renaissance Technologies LLC owned 3.14% of AquaBounty Technologies worth $113,000 at the end of the most recent quarter. 8.92% of the stock is owned by hedge funds and other institutional investors.

AquaBounty Technologies Stock Up 3.8%

Shares of AQB stock opened at $0.93 on Wednesday. The business has a 50-day moving average price of $0.94 and a two-hundred day moving average price of $1.15. AquaBounty Technologies has a 12-month low of $0.50 and a 12-month high of $2.95. The firm has a market cap of $3.62 million, a P/E ratio of -1.13 and a beta of 1.29.

Analyst Ratings Changes

Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of AquaBounty Technologies in a report on Monday, December 22nd. One investment analyst has rated the stock with a Sell rating, Based on data from MarketBeat, AquaBounty Technologies presently has an average rating of “Sell”.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc is a biotechnology company focused on aquaculture innovation through the development and commercialization of genetically engineered fish. Its flagship product, AquAdvantage Salmon, is an Atlantic salmon strain enhanced with a growth hormone gene that enables faster growth and more efficient feed conversion compared with conventional farmed salmon. By integrating biotechnology into seafood production, AquaBounty aims to address global protein demand while reducing the environmental footprint associated with marine aquaculture.

Founded in 1991, AquaBounty is headquartered in Maynard, Massachusetts, and operates a state-of-the-art, land-based incubation and grow-out facility in Panama.